Precision Neuroscience Raises $41 Million to Build and Scale the Next Generation of Treatments for Neurological Illnesses
Summary
Try refreshing your browser, or Precision Neuroscience Raises $41 Million to Build and Scale the Next Generation of Treatments for Neurological Illnesses NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) , the only braincomputer interface (BCI) company developing implants that are designed to be high-resolution, minimally invasive, and reversible, today announced a $41 million Series B funding round led by Forepont Capital Partners. The new financing enables Precision to continue hiring top talent, while powering further product development and paving the road to FDA regulatory review, expected in the coming months. The latest investment brings the companys total funding to $53 million in under two years.We imagine a world where devastating neurological conditions stroke, traumatic brain injury, dementia are finally treatable, Michael Mager, CEO of Precision Neuroscience, said. Precisions implant, the Layer 7 Cortical Interface, is a strip of flexible, thin film material similar to a piece of Scotch tape, but with a thickness that is 1/5th that of a human hair. We are building the only braincomputer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.